Similarly, a small study in patients with coronary artery disease (n = 10) showed that a 60-minute infusion of ET receptor blockade improved coronary vascular function as the coronary flow reserve improved significantly in reaction to substance P, an endothelial dependent vasodilator. This evidence concerns the gene TAC1 and coronary artery disorder.